SciFi Futures
← Concepts
Neurotechnology

Penfield mood organ

A domestic appliance whose dial schedules any emotional state on demand, from businesslike aggression to the desire to watch television.

In shortPenfield mood organ, from Do Androids Dream of Electric Sheep? (Philip K. Dick, 1968), is at technology readiness level 4 of 9 (validated in lab) at its weakest link. Held back by Closed-loop control of emotional state and Measurable neural biomarkers of mood and affect. Science status: consistent with known physics; key effects unproven at scale. Estimated new funding to unlock: $3.3B–16B.

Rick and Iran Deckard dial moods each morning from a Penfield mood organ, including a setting for the desire to dial.
Do Androids Dream of Electric Sheep? by Philip K. Dick, 1968Set in 1992Overdue34 years past the story's date; weakest link still at TRL 4

Closest todayBiomarker-driven closed-loop DBS for depression in single patients; FDA-approved adaptive DBS sensing for Parkinson's.

Dependency stack

Research TRL 1–3Development TRL 4–6Deployment TRL 7–9
Sort by
  • Selecting and holding a chosen emotional state is the device's whole function
    • Controlling severity of illness is not the same as selecting an arbitrary mood; the control space is undemonstrated
    • Tolerance, rebound and hedonic habituation under repeated stimulation are unmeasured
    • Open-loop safety; a device that can induce despair as easily as calm has no fail-safe design yet
    plausibleTRL 4
    • Closed-loop control needs a measurable state variable
      • Biomarkers do not generalize across people; each requires weeks of intracranial mapping
      • Ground truth is subjective self-report, so the mapping cannot be validated objectively
      • Emotion is not a small set of dials; no evidence that discrete states like "ersatz dread" are separately addressable
      plausibleTRL 4
    • A consumer appliance cannot require craniotomy; limbic targets must be reachable from outside
      ✕4 blockers›
      • Skull aberration and heating; each subject needs a CT-based acoustic model or custom metalens
      • Mechanism unclear (mechanosensitive channels vs thermal vs cavitation), so dose-response is empirical
      • Excitation versus inhibition depends on parameters in ways not yet predictable
      • Effects on a structure, not a circuit; cannot address specific cell types
      TRL 5
    • Implanted sensing and stimulation remains the only route with proven specificity
      ✕2 blockers›
      • Tissue response degrades signal over years
      • Channel count and wireless bandwidth
      TRL 6
      • Channel count is limited by wireless data and power budget
        ✕3 blockers›
        • Tissue heating caps implant power at a few hundred milliwatts, which bounds radio and compute
        • Raw broadband neural data exceeds the link, forcing on-implant spike detection and compression
        • Battery or wireless-power lifetime versus the decades a permanent interface implies
        TRL 5
        • Implant power density sets what telemetry and on-board compute are affordable
          ✕2 blockers›
          • Cycle life of lithium-metal anodes
          • Thermal runaway safety
          TRL 6
  • A dial needs a measurable state variable and a map from settings to states
    plausibleTRL 4
  • A household appliance cannot require implanted electrodes in limbic targets
    TRL 5
  • Specific contents like "the desire to watch television" are cognitive, not just arousal
    ✕3 blockers›
    • Models are subject-specific; decoders do not transfer across brains without recalibration
    • Non-invasive signals are slow and spatially coarse; invasive coverage is a few square centimetres
    • Encoding (write) models are far behind decoding; we cannot specify the activity for an arbitrary percept
    TRL 3

Who could unlock it

  • Across several requirements:
  • Katherine Scangos 2
  • Inner Cosmos 2
  • Helen Mayberg 2
  • Nudge 2
Closed-loop control of emotional stateTRL 4bottleneck
  • Katherine ScangosResearcher, UCSF
    Showed biomarker-triggered amygdala-guided stimulation relieved treatment-resistant depression in one patient (Nature Medicine 2021)
  • Motif NeurotechStartup
    Received FDA IDE in April 2026 for RESONATE, a trial of its blueberry-sized wireless DOT stimulator for depression; raised $30M+
  • Inner CosmosStartup
    Completed an FDA early feasibility study of a minimally invasive skull-embedded depression stimulator in 2025
  • MedtronicCompany
    BrainSense adaptive DBS, the first sensing closed-loop DBS, was FDA-approved for Parkinson's in February 2025
Measurable neural biomarkers of mood and affectTRL 4bottleneck
  • Katherine ScangosResearcher, UCSF Dolby Family Center for Mood Disorders
    Led the 2021 n-of-1 study that found a personalized amygdala gamma biomarker and used it to trigger closed-loop stimulation for depression
  • Helen MaybergResearcher, Icahn School of Medicine at Mount Sinai
    Her group used a sensing DBS device to identify a recording-based biomarker tracking recovery from treatment-resistant depression (NIH-reported, 2023)
  • Sameer ShethResearcher, Baylor College of Medicine
    Runs intracranial-recording-guided DBS trials for depression at Baylor and co-founded Motif Neurotech (PI of its 2026 RESONATE study)
  • UCSF Closed-Loop DBS ProgramAcademic lab
    Multi-subject program mapping personalized iEEG mood biomarkers before chronic closed-loop DBS, with a sham-controlled phase
Non-invasive focal deep-brain neuromodulationTRL 5
  • NudgeStartup
    Raised $100M Series A (2025) and runs near-daily human studies with its Nudge Zero focused-ultrasound system for pain and addiction
  • SanmaiStartup
    Raised $12M in 2025 to pursue an FDA-cleared transcranial focused ultrasound device with AI-assisted targeting
  • Mickael TanterResearcher, Institute Physics for Medicine Paris (Inserm, CNRS, ESPCI)
    Co-author of the metalens-corrected subcallosal-cingulate ultrasound depression study (Brain Stimulation 2025) and co-founder of SonoMind
  • Jan KubanekResearcher, University of Utah
    Developed the Diadem system for patient-specific, controlled ultrasound therapies of deep brain targets

Beyond engineering

  • Autonomy when the device can schedule the user's willingness to use it
  • Consumer safety regime for a device that can induce despair